Primary Care

Vasculitis

Questions discussed in this category

How would you manage active psoriasis and psoriatic arthritis in patient on Rituximab and prednisone for MPO positive vasculitis?

The patient has ongoing inflammatory arthritis despite methotrexate, apremilast, and jak inhibitor trials.

1 Answer available

How long do you continue PJP prophylaxis in a patient with GPA who is able to wean steroids and remains only on rituximab for maintenance therapy?

1 Answer available

What is your approach to maintenance treatment in a patient with Sjogren's who received rituximab for mononeuritis multiplex?

And how would you monitor response?

1 Answer available

Do you typically screen every patient with headaches after the age of 60 with ESR?

6 Answers available

Do you recheck screening labs (ESR, BUN/Cr, urinalysis, ANA, etc) for patients with recurrent small vessel vasculitis of unknown origin with each flare?

1 Answer available

What is your approach to further workup, monitoring, and treatment of Sjogren's syndrome patients with positive cryoglobulins but no clear signs of vasculitis?

1 Answer available

What is your approach to treatment for patients with microscopic polyangiitis who have sustained remission at 6 months after induction rituximab?

Is there a role for monitoring for relapse or increased disease activity as opposed to scheduled dosing?

1 Answer available

Do you generally recommend low dose aspirin for patients with giant cell arteritis?

2 Answers available

Would you advise a patient with quiescent vasculitis who flared with the first Covid mRNA vaccine to obtain an additional dose?

Would you suggest switching to a viral vector vaccine, such as J&J?

2 Answers available

How long do you continue steroid-sparing agents such as tocilizumab for GCA once the disease is in remission off steroids?

1 Answer available

How do you screen for colon cancer in patients with Behcet syndrome with colonic involvement?

1 Answer available

Do you monitor RS3PE patients for GCA with the same vigilance that you do in PMR patients?

1 Answer available

Is there a role for tocilizumab in treatment of polymyalgia rheumatica in patients who do not have features of giant cell arteritis or rheumatoid arthritis?

1 Answer available

Papers discussed in this category

Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica.

Ann Intern Med, 2020 Sep 22

Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study.

RMD Open, 2021 Sep

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.

Arthritis Rheum,

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.

The New England journal of medicine, 2013-08-01

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

Ann. Rheum. Dis., 2017 May 25

Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis.

N Engl J Med,

Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.

N Engl J Med,

Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.

Rheumatol Int, 2014 Jun 05

Identification of lymphoma predictors in patients with primary Sjögren's syndrome: a systematic literature review and meta-analysis.

Annals of the rheumatic diseases, 2011 Sep 16

Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry.

Current opinion in rheumatology, 2018 Jul

Trimethoprim-sulfamethoxazole and antineutrophil cytoplasmic antibodies-associated vasculitis.

European journal of medical research, 2009 Dec 07

Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement.

Annals of the rheumatic diseases, 2018 Jun 27

Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis.

Expert review of anticancer therapy, 2009-01

The NSABP Study of Tamoxifen and Raloxifene (STAR) trial.

Lancet Gastroenterol Hepatol, 2023 Feb 01

Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial.

Primary Care

Vasculitis

Questions discussed in this category

Papers discussed in this category

Related Topics in Primary Care